Skip to content

To test whether application of topical heparin solution around the IV cannula site daily would reduce the occurrence of superficial inflammation of veins when compared to a placebo

Efficacy of topical heparin in preventing superficial thrombophlebitis after peripheral intravenous cannulation: A placebo controlled randomized trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069653
Enrollment
108
Registered
2024-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I809- Phlebitis and thrombophlebitis ofunspecified site

Interventions

Intervention1: Heparin sodium (Topical) quick penetrating solution: Heparin sodium (Topical) quick penetrating solution is a topical form of heparin sodium will be applied thrice per day for 3 days Co

Sponsors

All India Institute of Medical Sciences, Mangalagiri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged 1 month-14 years admitted in inpatient department requiring IV cannulation for at least 72 hours 2.Parents who have given written informed consent

Exclusion criteria

Exclusion criteria: Children who required iv access in the last 28 days, have hypersensitivity to heparin, have any condition which has procoagulant tendency, already on anticoagulant therapy or planned for anti coagulant therapy, already on non-steroidal anti-inflammataory drugs or planned for non-steroidal anti-inflammataory drugs

Design outcomes

Primary

MeasureTime frame
The difference in proportion of children who have no phlebitis between the children who receive topical heparin quick penetrating solution and a topical placeboTimepoint: 72 hours

Secondary

MeasureTime frame
The difference in proportion of children who develop grade 1 or grade 2 phlebitis between the children who receive topical heparin quick penetrating solution and a topical placeboTimepoint: 72 hours;The mean difference of time in hours to develop grade 1 or grade 2 between the children who receive topical heparin quick penetrating solution and a topical placeboTimepoint: 72 hours

Countries

India

Contacts

Public ContactMahesh V

All India Institute of Medical Sciences, Mangalagiri

maheshvacharya@aiimsmangalagiri.edu.in7411747661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026